Hims & Hers Health, Inc. revised earnings guidance for the year 2022. For the full year, the company is raising revenue outlook to between $470 million and $485 million, which represents year-over-year growth of between 73% and 78%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.24 USD | -2.16% | -0.24% | +37.53% |
04-26 | Seaport Global Starts Hims & Hers Health With Buy Rating | MT |
04-16 | Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.53% | 2.69B | |
-39.72% | 2.17B | |
+23.23% | 536M | |
+42.77% | 467M | |
-65.08% | 157M | |
-37.84% | 74.88M |
- Stock Market
- Equities
- HIMS Stock
- News Hims & Hers Health, Inc.
- Hims & Hers Health, Inc. Revises Earnings Guidance for the Year 2022